Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The decrease in bone mass associated with aging and menopause

J N Heersche1, C G Bellows, Y Ishida

  • 1Department of Oral Physiology, Faculty of Dentistry, University of Toronto, Ontario, Canada.

The Journal of Prosthetic Dentistry
|February 25, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ovariectomy of 12-month-old rats: effects on osteoprogenitor numbers in bone cell populations isolated from femur and on histomorphometric parameters of bone turnover in corresponding tibia.

Cell and tissue research·2007
Same author

Different effects of insulin and insulin-like growth factors I and II on osteoprogenitors and adipocyte progenitors in fetal rat bone cell populations.

Calcified tissue international·2006
Same author

Effect of simulated weightlessness on osteoprogenitor cell number and proliferation in young and adult rats.

Bone·2005
Same author

Proliferation, differentiation and self-renewal of osteoprogenitors in vertebral cell populations from aged and young female rats.

Mechanisms of ageing and development·2003
Same author

The frequency of common progenitors for adipocytes and osteoblasts and of committed and restricted adipocyte and osteoblast progenitors in fetal rat calvaria cell populations.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2001
Same author

Resorptive state and cell size influence intracellular pH regulation in rabbit osteoclasts cultured on collagen-hydroxyapatite films.

Bone·2001

Bone loss after age 30 is significant. Progesterone, not just estrogen, may prevent postmenopausal bone loss, offering new therapeutic avenues for bone health and implant success.

Area of Science:

  • Bone Biology and Endocrinology
  • Gerontology and Reproductive Health

Background:

  • Human skeleton accrues bone until age 30, followed by gradual bone loss.
  • Estrogen replacement therapy mitigates postmenopausal bone loss, but estrogen deficiency's sole responsibility is uncertain.
  • Progesterone deficiency is also implicated in bone mass decrease, with progesterone therapy showing promise in preventing bone loss linked to ovarian dysfunction.

Purpose of the Study:

  • To review bone remodeling and age/gender-related bone loss.
  • To discuss evidence for progesterone's role in bone formation.
  • To propose future research for predicting implant therapy success based on osteoprogenitor cells.

Main Methods:

  • Literature review on bone remodeling and loss.
  • Analysis of studies in rats investigating progesterone's effect on bone formation.

Related Experiment Videos

  • Synthesis of findings to suggest future research directions.

    • Main Results:

    • Progesterone plays a crucial role in regulating bone formation, as evidenced by rat studies.
    • Progesterone replacement therapy can prevent bone loss associated with ovarian dysfunction.
    • Osteoprogenitor cell characteristics may predict implant therapy outcomes.

    Conclusions:

    • Progesterone is a key factor in maintaining bone mass, alongside estrogen.
    • Understanding progesterone's role can lead to improved treatments for postmenopausal bone loss.
    • Future research should focus on osteoprogenitor cell analysis for personalized implant therapy.